Context Capital Management, LLC
Position in SLXN — Silexion Therapeutics Corp
CIK 1301396
LAJOLLA, CA
Position in SLXN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$0
+$0 QoQ
Shares Held
51,183
0.0% QoQ
Ownership
0.921%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Context Capital Management, LLC holds $19,316,305 across 9 Biotechnology names. SLXN ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
46,000 | $14,540,140 | |
| 2 | GOSS |
Gossamer Bio, Inc.
|
361,831 | $4,776,165 | |
| 3 | MLEC |
Moolec Science SA
|
32,653 | $0 | |
| 4 | TVGN |
Tevogen Inc.
|
97,250 | $0 | |
| 5 | VRXA |
Veraxa Biotech AG - Post de-SPAC
|
100,000 | $0 | |
| 6 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
81,500 | $0 | |
| 7 | APLM |
Apollomics Inc.
|
298,500 | $0 | |
| 8 | SLXN |
Silexion Therapeutics Corp
This page
|
51,183 | $0 |
No Holdings History
No holdings records found for this institution in SLXN.